SPRINTR research is designed to accelerate precision medicine in prostate cancer. It will facilitate high quality biomarker research, clinical trial design, recruitment, and follow-up, drug discovery, and health economy and quality of life assessment. It comprises four integrated parts, all adding critial components to the open research infrastructure.